Product Theater Presentations

Product Theaters are not designated for CME credit. It’s a great way to see the hottest pediatric medical devices and products while being revitalized for an afternoon of learning.


Saturday, November 3 • 12:30PM – 1:00PM

Product Theater A, Booth 158

Understanding Human Papillomavirus (HPV): Disease Awareness and Current Guidelines

Presented by: Kenneth Alexander, MD, PhD
Division Chief, Division of Infectious Diseases, Department of Pediatrics
Nemours Children’s Health System

Learning Objectives:

  • Provide an overview of certain HPV-related diseases
  • Review CDC recommendations
  • Understand the rationale and potential strategies for clear HCP communication about HPV

Presenting Company: Merck

Product Theater B, Booth 1161

“Probiotics and Prebiotics in the First 1000 days – Their Impact on Long Term Health”

Presented by: Michelle Pietzak, MD
Pediatric Gastroenterology
LAC+USC Medical Center
Children’s Hospital of Los Angeles

Learning Objectives:

  • Review the importance of the developing microbiota
  • Discuss probiotics and prebiotic human milk oligosaccharides (HMOs) used in infant formula
    • Probiotics
      • Bifidobacterium lactis (B. lactis)
        • Immune system support
      • Lactobacillus reuteri (L. reuteri)
        • Reduced crying time in colicky infants
        • Reduced frequency of spit ups
      • Prebiotic
        • 2-fucosyllactose (2’FL)
          • Immune system support

Complimentary Box Lunch will Be Provided to the first 100 attendees.

Presenting Company: Nestlé/Gerber Products Company

Product Theater C, Booth 1459

Help Protect Them During Peak Risk Years: Serogroup B Meningococcal Disease Vaccination in Adolescents and Young Adults

Presented by: Dr Elizabeth Race, MD
Infectious Disease Specialist

Complimentary box lunch will be provided on a first come, first serve basis. 

Presenting Company: Pfizer Inc

Saturday, November 3 • 1:15PM – 1:45PM

Product Theater A, Booth 158

Spotlight on Mild-to-Moderate Atopic Dermatitis: An Update on Steroid-Free Topical Prescription Therapy

Presented by: Dr. Cory Rubin

Program Description:

Join us for an interactive presentation on a steroid-free topical therapy for the treatment of mild-to-moderate atopic dermatitis. Expert faculty will guide the audience through an in-depth look into the product and answer questions to help attendees gain a better understanding of this treatment option.

Presenting Company: Pfizer Inc

Product Theater B, Booth 1161

New Approaches to Allergy Management

Presented by: Benjamin D. Gold, MD, FAAP, FACG
Children’s Center for Digestive Healthcare, LLC
Gi Care for Kids, LLC
Atlanta, GA

Learning Objectives:

  • Review the emerging concepts of active management of food allergy, including approached to treatment
  • Discuss the latest clinical evidence in food allergy management to support better outcomes and improve quality of life for patients and their families.

Presenting Company: Mead Johnson Nutrition

Product  Theater C, Booth 1459

Medical Mystery “A Case Study: A Neuromuscular Disorder With Delay in Motor Milestones” 

Presented by: Melissa Svoboda, MD
Assistant Professor of Pediatrics
Baylor College of Medicine
Pediatric Neurologist
Children’s Hospital of San Antonio
San Antonio, TX

Program Description:

Participants are invited to work with us to discover the cause of our patient’s symptoms in this interactive case study.

Presenting Company: Biogen

Sunday, November 4 • 12:30PM – 1:00PM

Product Theater A, Booth 158

Make the ACIP-Recommended 16-Year Immunization Platform Visit a Health Care Priority

Presented by: Oliver T. Brooks, MD, FAAP
Chair, Immunize LA Families Coalition
Medical Director and Chief of
Pediatric and Adolescent Medicine
Watts Healthcare Corporation
Los Angeles, California

Program Description: This presentation will review the Advisory Committee on Immunization Practices’ creation in 2017 of a separate column for age 16 years on the vaccination schedule, examine how that change may help address low immunization rates, and discuss what health care providers can do to implement an immunization and preventive care platform visit at 16 years of age.

Complimentary lunch will be provided for the first 100 attendees. Please arrive early as space is limited. No preregistration is required.

Presenting Company: Sanofi Pasteur

Product Theater B, Booth 1161

Problem-Based Learning – An Interactive Discussion – Pediatric Patient with Severe Uncontrolled Asthma

Presented by: Randall Brown, MD MPH AE-C
Pediatrician & Pulmonologist
Director, Asthma and COPD Programs
Center for Managing Chronic Disease
University of Michigan
Ann Arbor, Michigan

Program Description:  Problem Based Learning (PBL) is an interactive, case-based educational forum that progressively discloses relevant clinical data while participants are encouraged to actively think through the case just as you would in your office or clinic. The primary purpose of this forum is to improve patient outcomes by changing practitioners’ behavior toward following evidence-based guidelines with new information about management options. The PBL facilitator will guide the discussion and interaction of the group as they work together to solve a clinical problem.

Lunch being offered on a first come, first serve basis.

Presenting Company:  Novartis Pharmaceuticals Corporation

Product Theater C, Booth 1459

The Emerging Science of the Skin Microbiome and What it Means for Your Patients

Presented by: Kimberly A. Capone, PhD, Head, Microbiome Platform, Emerging Science & Innovation, Johnson & Johnson Consumer Inc.

12:15 – 12:30 PM Check In & Lunch

12:30 – 1:00 PM Program

Program Description:

Microbial colonization of the human skin begins with the first significant exposure of birth. Proper establishment of a healthy skin microbiome plays an essential role in limiting access to harmful or infectious microbes and may also play a role in immune modulation. Microbiome imbalances (dysbiosis) can be associated with skin diseases, such as atopic dermatitis, and as such can impact the management of this inflammatory skin disease.   This presentation shares the latest research on the development of the skin microbiome in infancy and beyond and informs on the essential role of a healthy skin microbiome while providing practical advice on how to care for it that you can share with your patients.

Kimberly A. Capone, PhD, is a leading researcher studying the human skin microbiome, and particularly the infant skin microbiome, identifying new insights with potential to lead to innovative healthcare solutions.

Presenting Company: Johnson & Johnson Consumer Inc.

Sunday, November 4 • 1:15PM – 1:45PM

Product Theater A, Booth 158

“Evidence based recommendations of L. reuteri Protectis in colic, constipation and functional abdominal pain.” 

Presented by: José M Garza MD, MS
Neurogastroenterology and Motility Medical Director
Children’s Healthcare of Atlanta

Pedro Gutiérrez-Castrellón MD, MSc, DSc
Head of Translational Research on Mother-Child Health
Center for Research on Microbiota & Pre/Probiotics
Hospital General GEA. Mexico

Learning objectives:

  • Understand the unique characteristics of the probiotic L. reuteri Protectis and the modes of action
  • Review the scientific data of L. reuteri Protectis in infantile colic, functional constipation and functional abdominal pain

Complimentary lunch will be provided for the first 100 attendees. Please arrive early as space is limited. No preregistration is required.

Presenting Company: BioGaia/Everidis

Product Theater B, Booth 1161

The Milk Fat Globule Membrane (MFGM): Understanding Bioactive Components in Human Milk

Presented by: Fayez K. Ghishan, MD
The University of Arizona
Horace W. Steele Endowed Chair in Pediatric Research
Professor and Head, UA Department of Pediatrics
Director, UA Steele Children’s Research Center

Learning Objectives:

  • Discuss how human milk inspires the design of infant formula for beneficial outcomes.
  • Describe the unique characteristics and bioactive components of the milk fat globule membrane (MFGM)
  • Explore data demonstrating the beneficial effects of MFGM ingredients on brain developments and immune health in infants and young children.

Presenting Company: Mead Johnson Nutrition

Product Theater C, Booth 1459

The Science & Opportunity In Food Allergy Prevention: How To Feed Babies To Reduce Risk

Presented by: Ruchi Gupta, MD MPH
Professor of Pediatrics and Medicine, Northwestern University
Director, Science and Outcomes of Allergy and Asthma Research (SOAAR)

Dave Stukus, MD
Assistant Professor of Pediatrics in the Section of Allergy/Immunology at Nationwide Children’s Hospital

Program Description:
Presentation will explore new research supporting the benefits of early & often exposure of potentially allergenic foods to babies and young children. A review of new research on diet diversity, optimizing skin care, and multi-protein exposures early in life for food allergy prevention. An interactive session to dispel myths and drive home new feeding guidelines while illuminating science on the ways that feeding multiple foods early can amplify protection against food allergies.


  • Review seminal research on infant dietary allergen exposure and new feeding guidelines for “early & often”: LEAP, E.A.T. PETIT studies
  • Understand causes for widespread increased susceptibility to food allergies
  • Clarify the relationship between eczema and food allergies by understanding the Dual Allergen Exposure Hypothesis and ways optimal skin care can protect against food allergies
  • Introduce the next frontier of food allergy research, specifically around Multi-Protein Synergy
  • Review emerging data from Stanford University’s Sean N. Parker Center for Allergy and Asthma Research on immunomodulatory properties of dietary protein

Complimentary box lunch will be provided for the first 200 attendees.

Presenting Company: SpoonfulOne

Monday, November 5 • 12:30PM – 1:00PM

Product Theater A, Booth 158

What’s Bugging your Patient? A Game-Changing approach to Infectious Disease Diagnostics.

Presented by: Kenneth Alexander, MD, PhD
Division Chief, Division of Infectious Diseases, Department of Pediatrics
Nemours Children’s Health System

Dr. Kenneth Alexander, Pediatric ID specialist from Nemours Children’s Hospital in Orlando, will present challenging pediatric clinical cases in the diagnosis of meningitis and acute respiratory illness.  Come test your knowledge on infectious disease diagnostics and learn how a rapid, syndromic approach using the Meningitis/Encephalitis and Respiratory Panels from BioFire Diagnostics has changed patient care at this children’s hospital.

Boxed lunches will be provided.

Presenting Company: BioFire Diagnostics

Product Theater B, Booth 1161

Recognizing the Signs of Central Precocious Puberty (CPP) Earlier: Journey from Patient to Referral Through Case Studies

Presented by: Karen Oerter Klein, MD

Program Description

This symposium will use the journey from patient to referral to help the clinician evaluate the timing of puberty in children, recognize early signs of precocious puberty, know when to be concerned, and when to refer to a pediatric endocrinologist. It will include essentials of regular physical pubertal exams, growth rate evaluation, and screening protocols. It will present current treatment options and the pediatrician’s role in management. It will review updated outcomes on the psychosocial health of children with early puberty, and growth outcomes after treatment with GnRHa.

Program Objectives

  • Recognize the early clinical signs of central precocious puberty
  • Describe the decision-making process of when to refer a patient to a pediatric endocrinologist
  • Understand the general pediatrician’s role in the clinical care of a child with central precocious puberty
  • Understand the psychosocial and growth issues related to precocious puberty and its treatment
  • Journey from patient to referral through case studies

Lunch will be provided on a first come, first serve basis.

Presenting Company: AbbVie, Inc.

Product Theater C, Booth 1459

“Infant Anaphylaxis and an FDA-approved Treatment Option”

Presented by: Ruchi S. Gupta, MD, MPH, FAAP, FAAAAI, FACAAI

Registration begins at 12:15PM EST

Program Description:

Program Description: Incidences of anaphylaxis in infants, toddlers, and children have been on the rise. Now, there is an FDA-approved epinephrine auto-injector available for patients weighing 7.5 to 15 kg. This program will cover recently published data, guidelines that recommend early introduction of peanut-containing foods in certain infants, infant anaphylaxis, and an FDA-approved 0.1 mg epinephrine auto-injector that helps address this previously unmet medical need.

Food and Beverages will be served.

Presenting Company: kaléo

Monday, November 5 • 1:15PM – 1:45PM

Product Theater A, Booth 158

Staying on Schedule with Pediatric Vaccines: 2 Combination Vaccines to Help Improve Coverage and Compliance

Presented by: W. Michael Brown, MD, FAAP | Associate Director Family Medicine Residency | Chairman, Department of Pediatrics | Director of Pediatric Education | Bayfront Health St. Petersburg

Complimentary lunch will be provided for the first 100 attendees. Please arrive early as space is limited. No pre-registration is required.

Presenting Company: Sanofi Pasteur

Product Theater B, Booth 1161

Pediatric Atopic Dermatitis: The Burden Is More Than Skin Deep

Presented by: Elaine Siegfried, MD
Professor of Pediatrics and Dermatology
Saint Louis University School of Medicine
Director, Division of Pediatric Dermatology
Cardinal Glennon Children’s Hospital
St. Louis, Missouri

“ATOPIC DERMATITIS is much more than red, itchy skin. It is a common, systemic, chronic inflammatory disease that can have a LIFE-LIMITING IMPACT on the lives of the CHILDREN and ADOLESCENTS who suffer from it. Regeneron and Sanofi Genzyme invite you to discover how looking beyond signs and symptoms can help shed important insights into this disease.”

Food & Beverage will be provided

Presenting Company: Regeneron and Sanofi Genzyme

Product Theater C, Booth 1459

“Meningococcal Disease: A Survivor’s Story”

Presented by: Jamie Schanbaum and Leonard Friedland

Vaccine-preventable diseases, such as bacterial meningitis, are continuing to impact our communities and college campuses. Meningococcal disease, commonly called meningitis, is an uncommon, but sudden and potentially life-threatening illness. Jamie has shown tremendous strength and perseverance as she endeavors to promote awareness as a GSK spokesperson of meningococcal disease and its potential consequences.

Light refreshments to be provided.

Presenting Company: GSK